Brief: Neuland Laboratories Says U.S. FDA Concluded Unit 3 Manufacturing Facility Inspection Is "Closed"
July 13 (Reuters) - Neuland Laboratories Ltd NEUL.NS :
* U.S.FDA HAS ISSUED AN ESTABLISHMENT INSPECTION REPORT
AGAINST
THE INSPECTION CONDUCTED AT UNIT 3 MANUFACTURING FACILITY
* U.S.FDA HAS CONCLUDED THAT THIS INSPECTION IS "CLOSED"
Source text for Eikon: ID:nNSE8qpqkM
Further company coverage: NEUL.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Neuland Laboratories
See all newsIndia's Neuland Laboratories jumps after approving $13.3 mln land purchase for expansion
Brief: Neuland Laboratories Approves Capital Expenditure Of 1.26 Billion Rupees For Land Purchase In Kakinada
Brief: Neuland Laboratories Says US FDA Inspects Neuland Laboratories Unit 3 From August 10 To 14, 2026
Brief: Neuland Laboratories June-Quarter Consol Profit 1.48 Billion Rupees
Brief: Neuland Laboratories March-Quarter Consol Profit 2.13 Bln Rupees